APA (7th ed.) Citation

Emdormi Rymbai, Deepa Sugumar, Jubie Selvaraj, Ram Kothandam, & Divakar Selvaraj. (2023). Modulation of Nrf2 by Activation of Estrogen Receptor β as a Therapeutic Strategy to Prevent Cancer Development and Overcome Inflammation-Related Drug Resistance in Breast Cancer. Tabriz University of Medical Sciences.

Chicago Style (17th ed.) Citation

Emdormi Rymbai, Deepa Sugumar, Jubie Selvaraj, Ram Kothandam, and Divakar Selvaraj. Modulation of Nrf2 by Activation of Estrogen Receptor β as a Therapeutic Strategy to Prevent Cancer Development and Overcome Inflammation-Related Drug Resistance in Breast Cancer. Tabriz University of Medical Sciences, 2023.

MLA (9th ed.) Citation

Emdormi Rymbai, et al. Modulation of Nrf2 by Activation of Estrogen Receptor β as a Therapeutic Strategy to Prevent Cancer Development and Overcome Inflammation-Related Drug Resistance in Breast Cancer. Tabriz University of Medical Sciences, 2023.